Several lines of inquiry have indicated that glycine plays an important role in both glutamatergic neu rotransmission and pathophysiology of cerebral ischemia, However, subacute outcome trials demonstrating the effi cacy of glycine antagonists as neuroprotectants have not been performed with rigorous control of brain temperature, In this study, we investigated the effect of N-methyl-D aspartate (NMqA) receptor glycine recognition site antag onism in a temperature-controlled rodent model of tran sient focal ischemia. Male Wistar rats underwent 75 min of intraluminal middle cerebral artery occlusion (MCAO),
h (High-Dose) for 24 h, Cortical temperature was con trolled at 38,0 ± 0,1 DC during MCAO and the first 6 h of reperfusion, A 7-day recovery interval was allowed, Mean total infarct volume was reduced by -40% in both high and low-dose groups (p < 0.01), The preponderance of infarct reduction occurred in the cortex (p < 0,01), Neuro logic function correlated with the size of cerebral infarct (p = 0,001), Neurologic grade was similarly improved by treatment with either dose (p = 0,01), These results demon strate that neuroprotection achieved by antagonism of the glycine recognition site persists when brain temperature is controlled, indicating a potent mechanism of action other than attenuating a hyperthermic response to ischemia, Key Words: NMDA-Glycine antagonists-Neuroprotec tion-Brain temperature-Ischemia, strated to potentiate glutamate toxicity in cultured neurons (Johnson and Ascher, 1987) . Finally, intersti tial glycine concentrations become substantially in creased during an ischemic insult and remain elevated for prolonged intervals after reperfusion (Baker et al., 1991; Globus et al., 1991) .
Recently, several compounds have been synthe sized that are potent and selective antagonists of the strychnine-insensitive glycine receptor. In laboratory models of either ischemia or head trauma, a reduction in injury has been observed following use of these drugs (Gill et al., 1995; Newell et al., 1995; Takano et al., 1996; Tsuchida and Bullock, 1995; Warner et al., 1995b ). Our previous work with one such compound, 5-nitro-6,7-dichloro-2,3-quinoxalinedione (ACEA 1021) (Woodward et al., 1995) , examined infarct volume in awake rats undergoing intralumi nal middle cerebral artery occlusion (MCAO) (War ner et al., 1995b ). Although marked protection was observed, brain temperature was not controlled.
Rectal temperature was monitored and a clear dose dependent effect of the drug in inhibiting a hyper thermic response to ischemia was observed.
Numerous investigations have shown that the ex tent of ischemic brain damage is influenced by brain temperature during the ischemic interval (Busto et ai., 1989; Chen et ai., 1993; Colbourne and Corbett, 1995; Ridenour et ai., 1992) . In the intraluminal MCAO model, it has been shown that ischemia in duces a transient episode of hyperthermia (Kuluz et ai., 1993; Zhao et ai., 1994) . Hyperthermic tempera ture increases of as little as 1.2°C have been shown to nearly double the size of the resultant infarct (War ner et ai., 1993) . Therefore, the possibility is real that the previously reported protective effects of glycine recognition site antagonism represent only tempera ture-reducing effects of this class of compounds. Ac cordingly, a study was designed to examine this issue.
METHODS AND MATERIALS
This study was approved by the Duke University Animal Care and Use Committee. Male Wistar rats (aged 8-10 weeks) were anesthetized with 40 mg/kg i.p. sodium pento barbital (Nembutal, SO mg/ml, Abbott Laboratories, North Chicago, IL U.S.A.). Each animal was positioned in a stereotactic �ead frame. A midline scalp incision was made.
One mm lateral to midline, a burr hole was drilled over the left hemisphere at bregma = +2 mm. A radiotelemetry thermistor (Brain Probe, model XM-FH, Mini Mitter, Inc. Sunriver, OR, U.S.A.) was advanced into the cerebral cor tex to a depth of -2 mm. The probe was fixed in place with two cranial screws and orthodontic resin. The wound was closed with suture and animals were returned to their cages after recovery of the righting reflex.
Prior to this procedure, the temperature probe was cali brated in a circulating water bath against a mercury ther mometer within the range of 3S.0-40.0°C. This allowed extrapolation of temperatures from calibration points in accordance with the radiofrequency emitted by the thermis tor. Radiofrequency signals from the radiothermistor were At 2-4 days following the above procedure, rats were fasted from food for 12-14 h but allowed free access to water. They were then anesthetized with 1-2% halothane in SO% 02ibalance N2, (vol/vol) delivered via snout mask, and allowed to breathe spontaneously. Via incision, a cath eter was placed into the tail artery to monitor MABP and to sample blood. Via a lateral cervical skin incision, a cathe ter was placed into the left external jugular vein. This cathe ter was filled with saline, tunneled subcutaneously, and exteriorized on the nape of the neck.
Animals were then prepared for middle cerebral artery occlusion (MCAO) using modifications of techniques de scribed by others (Memezawa et aI., 1992; Zea Longa, et aI., 1989) . Via a right lateral cervical skin incision, the right J Cereb Blood Flow Metab. Vol. 17, No.2, 1997 common carotid artery (CCA) was identified. The external carotid artery (ECA) was isolated, and the occipital, supe rior thyroid, and external maxillary arteries ligated and divided. The internal carotid artery (lCA) was then dis sected distally until the origin of the pterygopalatine artery was visualized. Following surgical preparation, a 20-min interval was allowed for physiological stabilization. During this interval, arterial blood was sampled to measure pH, P A O2, P aC02, plasma glucose, and hematocrit.
Rats then underwent 7S min of MCAO. A 0.2S mm diameter nylon filament was inserted into the ECA stump and advanced -23 mm into the ICA to occlude the middle carotid artery (MCA). Immediately after filament inser tion, the neck wound was closed with suture and halothane was immediately discontinued allowing the animal to promptly awaken. Animals were then placed in a lO-L Plexiglas box containing SO% 02/S0% N2 (vol/vol).
Animals were randomly assigned to one of three groups: At 10 min after filament removal, halothane was discon tinued and the rats were allowed to awaken. Rats were returned to the Plexiglas box for an additional 6 h of tem perature control. Brain temperature was controlled as fol lows. During MCAO and the first 6 h of reperfusion, corti cal temperature was regulated at a target temperature of 38.0°C. If the cortical temperature was <38°C, a heat lamp was automatically turned on. If cortical temperature was > 38.0°C, chilled room air was blown over the surface of the animal by automated switching of an air-line solenoid valve.
At 24 h after filament removal, the respective infusion regimens were discontinued. Rats were administered -1 % halothane in SO% 02/S0% N2 (vol/vol) via snout mask. The jugular venous catheter was surgically removed. After re covery, animals were returned to their cages for the remain der of the 7-day post ischemic recovery interval.
All animals were evaluated neurologically 7 days after reperfusion. Each rat was assigned a score of 0-3, where o = no observable deficit, 1 = forelimb flexion, 2 = de creased resistance to lateral push without circling, and 3 = same behavior with circling (Bederson et ai., 1986) . Neuro logical examination was performed by one observer blin ded to group assignment.
Following neurological evaluation, animals were weighed, anesthetized with halothane, and killed by decapi tation. The brain was removed and frozen at -20DC in 2- 
RESULTS
Physiologic values for the three experimental groups are given in Total cerebral infarct volumes are presented in Fig. 1 . A main effect for each treatment group was observed (p = 0.001). Both ACEA 1021 treatment regimens produced a similar but significant (p < 0.01) reduction in total infarct volume within the range of 40-45% versus vehicle. Cortical infarct volume was significantly reduced by both doses of drug (Vehi cle = 76 � 16 mm3; Low-Dose = 30 ± 37 mm3; High Dose = 38 ± 33 mm3, p < OJ)1). Although a trend was present (Vehicle = 76 ± 18 mm3; Low-Dose = 57 ± 30 mm3; High-Dose = 53 ± 19 m3), ACEA 1021 failed to significantly reduce subcortical infarct volume (p = 0.07).
There was no evidence of grand mal type seizure activity in any animal. A few rats were noted to have hemifacial spasm ipsilateral to the lesion during the 6-h recovery interval. This was not associated with treatment group. There were no strokc related deaths. Neurologic function correlated with the size of cerebral infarct (p = 0.(01), although circling was not uniformly present in animals with larger infarcts.
Neurologic grade was improved by treatment with either dose of the glycine recognition site antagonist (p = 0.01) (Fig. 2) . Low-and High-Dose groups designate, respectively, rats that received ACEA 1021 i.v. either as a 5 mg/kg bolus followed by a 24-h infusion at 3.5 mg/kg/h or a 10 mg/kg bolus followed by a 24-h infusion at 7 mg/kg/h. Antagonism of the NMDA receptor glycine recognition site resulted in significant improvement in neu rologic grade (p = 0.01) at either dose when compared to vehicle.
DISCUSSION

Results
1021 (Warner et al., 1995b) . In the present study, a -60% reduction in mean cortical infarct size was observed, indicating the robust nature of glycine rec ognition site antagonism as a strategy for neuropro tection even within a temperature-regulated model.
Antagonists of the glycine recognition site have received increasing attention as potential pharmaco logic approaches to treatment of ischemic/traumatic brain injury for several reasons. To date, adverse psychotomimetic effects of these compounds have not been observed, a potential distinct advantage over both competitive and noncompetitive NMDA receptor antagonists (Balster et al., 1995; Grotta et aI., 1995) . As clinical trials of glycine recognition site antagonists commence, it will be important to learn if this distinction persists.
Further, the neuroprotective efficacy of glycine recognition site antagonism has recently been dem onstrated across a spectrum of both in vitro and in vivo ischemia models. For example, Newell et al. (1995) examined both 7-chlorokynurenic acid and ACEA 1021 in a hippocampal slice culture model subjected to oxygen-glucose deprivation (Newell et al., 1995) . Both compounds caused a dose-dependent reduction in CAl damage. This protection was re versed by increasing the extracellular concentration of glycine. MK-801, a noncompetitive NMDA antag onist, offered similar protection, which was resistant to glycine administration. Others, using in vivo mod els, have found reduction of focal ischemic infarct volume by i.v. injection of L-687414, a partial agonist of the glycine site, although only a 4-h recovery inter val was allowed (Gill et al., 1995) . Tsuchida and Bul lock (1995) also found protection from glycine recog nition site antagonism. In their experiment, rats were subjected to an acute compression injury caused by induction of a subdural hematoma (Tsuchida and Bullock, 1995) . ACEA 1021 was found to result in a reduction of infarct size by up to 39%. None of the above in vivo experiments allowed recovery from anesthesia and all used halothane. Halothane itself has previously been shown to offer substantial protec tion from focal ischemic injury (Warner et al., 1995a) .
Therefore, the contribution of halothane to the ob served protection, either by direct mechanisms or via an interaction with the glycine antagonist, is un known.
Another cause for concern regarding the reported neuroprotection afforded by glycine site antagonists relates to brain temperature. In the gerbil forebrain ischemia model, i.p. injection of 7 -Cl-thio-kynurenate caused a near total protection against CAl injury, but this protection was substantially attenuated when the effect of the drug on rectal temperature had been accounted for (Pellegrini-Giampietro et al., 1994) .
With respect to focal ischemia, it has been shown that the filament MCAO model often results in a hyperthermic response to the ischemic challenge (Kuluz et al., 1993; Zhao et al., 1994) . We have pre viously identified a substantial neuroprotective effect for the glycine recognition site antagonists ACEA 1021 and ACEA 1031 using the filament MCAO model (Warner et aI., 1995b) . However, during those experiments, both drugs were observed to inhibit the hyperthermic response seen in untreated animals during the ischemic insult.
Because of the potential halothane anesthesia con found and also because of reports that the neuropro tective effects of other NMDA receptor antagonists are temperature-dependent (Hoffman and Boast, 1995; Memezawa et al., 1995) , the current study was performed to address both the halothane and tem perature issues. Attempts were made to minimize exposure to halothane, although the necessity of an esthesia for surgical preparation and removal of the filament remained. Further, brain temperature was controlled both during ischemia and for a sub stantial interval after onset of reperfusion. We chose to implant the radio thermistor in the contralateral hemisphere to avoid confounds from spreading de pression, which could have been elicited by the thermistor. Pilot studies were performed on halo thane anesthetized animals to assure that contralat- ship was absent (r2 = 0.01; p = 0.65). These findings are in contrast to those of our previous work (Warner et aI., 1995b) . A preischemic plasma ACEA 102 1 concentration of 41 ± 9 JLg/ml (measured 50 min following 10 mg/kg i.p.) resulted in a 48% reduction in cortical infarct volume when compared to control values. A further 23% reduction of infarct volume occurred at an ACEA 1021 plasma concentration of 69 ± 27 JLg/ml (measured 50 min following 30 mg/ kg i.p.). We speculate that the greater reduction in infarct volume observed at the higher ACEA 1021 concentrations in that study are attributable to dose dependent effects on brain temperature. Neverthe less, larger doses of ACEA 1021 could be examined with temperature regulation to assure that the ceiling effect has been achieved in the current study. How ever, prior work demonstrated that ACEA 1021 con centrations of 84 JLg/ml cause loss of righting reflex and absence of withdrawal from deep noxious stimuli (McFarlane et aI., 1995) . Therefore, doses substan tially larger than those administered in the current experiment would likely result in profound sedation.
In conclusion, an NMDA receptor glycine recogni tion site antagonist was administered i.v. after onset of 75 min of temporary MCAO, and administration was continued for 24 h after reperfusion. This re sulted in an -60% reduction in mean cortical infarct volume as assessed 7 days later. This occurred despite strict regulation of brain temperature during ischemia and for the first 6 h of recovery. These data are in agreement with those of other studies using more acute models of injury that have identified neuropro tection from this class of compounds and, therefore, confirm an important role for glycine in the pathoge netic mechanism of ischemic brain damage. Further study is required to determine if this class of com pounds provides lasting benefit when administration begins at substantial intervals after reperfusion.
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